How to Preserve Muscle Mass on Weight-Loss Drugs Like Wegovy

Translate to Spanish or other 102 languages!

How can you preserve muscle mass if you are using GLP-1 drugs for weight loss? Top experts weigh in. Image for illustration purposes
How can you preserve muscle mass if you are using GLP-1 drugs for weight loss? Top experts weigh in. Image for illustration purposes
- Advertisement -

The development of glucagon-like peptide-1 (GLP-1) drugs, such as Wegovy and Zepbound, has ushered in a new era in weight management. While these drugs can lead to significant weight loss, researchers and medical professionals have raised concerns about the accompanying loss of muscle tissue. This Special Feature discusses the challenges associated with assessing changes in muscle mass that accompany GLP-1 drug-induced weight loss, the potential impact of muscle mass loss, and how to preserve muscle mass.

Follow the link below to Medical News Today to read the full story:

https://www.medicalnewstoday.com/articles/how-to-preserve-muscle-mass-on-weight-loss-drugs-like-wegovy

- Advertisement -

Information: https://www.medicalnewstoday.com

- Advertisement -
- Advertisement -

- Advertisement -

More Articles

Speak Up, Reach Out: STHS Behavioral Tackles Suicide Prevention

Not all wounds are visible. Every day, people struggle with emotional pain, depression and feelings of hopelessness that may go unnoticed by those around them.

Texas Oncology to Host Breast Cancer Awareness Symposium in McAllen. FULL TO CAPACITY. NO MORE ROOM.

The Breast Cancer Awareness Symposium 2026 is an educational and networking event hosted by Texas Oncology and sponsored by Caris Life Sciences, bringing together oncology specialists, surgeons, advanced practice providers, and community healthcare professionals to discuss the latest advances in breast cancer prevention, diagnosis, treatment, survivorship, and reconstruction. The symposium's theme, "Breast Cancer 2026: Early Detection, Modern Care, and Survivorship Through Community Partnership," highlights the importance of multidisciplinary collaboration and patient-centered care

The Connection Between Diet and Breast Cancer Risk

October is Breast Cancer Awareness Month, and many people may be wondering how to lower their risk.

FDA Approves Immunotherapy Regimen Studied by Mayo Clinic for Stage 3 Colon Cancer

The Food and Drug Administration (FDA) has approved the immunotherapy drug atezolizumab in combination with chemotherapy for some patients with stage 3 colon cancer following surgery. The treatment is for patients whose tumors have deficient DNA mismatch repair, or dMMR.
- Advertisement -